Skip to content
10-Q

Quarterly Report

PROTECT PHARMACEUTICAL Corp

0001551163-16-000549

← back to feed
Filed
Nov 21, 2016 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2016 · Sep 30, 2016 1.11M sh
Cash And Equivalents Q3 2016 · Sep 30, 2016 $45
Cash And Equivalents Q3 2016 · Dec 31, 2015 $7
Cash And Equivalents Q3 2016 · Sep 30, 2015 $164
Cash And Equivalents Q3 2016 · Dec 31, 2014 $502
Stockholders Equity Q3 2016 · Sep 30, 2016 −$835
Stockholders Equity Q3 2016 · Dec 31, 2015 −$100.45K
Current Liabilities Q3 2016 · Sep 30, 2016 $880
Current Liabilities Q3 2016 · Dec 31, 2015 $100.45K
Total Liabilities Q3 2016 · Sep 30, 2016 $880
Total Liabilities Q3 2016 · Dec 31, 2015 $100.45K
Current Assets Q3 2016 · Sep 30, 2016 $45
Current Assets Q3 2016 · Dec 31, 2015 $7
Total Assets Q3 2016 · Sep 30, 2016 $45
Total Assets Q3 2016 · Dec 31, 2015 $7
Operating Cash Flow restated Q3 2016 · Sep 30, 2015 −$15.49K
Sga Expense Q3 2016 · Sep 30, 2015 $1.65K
Sga Expense Q3 2016 · Sep 30, 2015 $1.86K
Net Income Q3 2016 · Sep 30, 2015 −$615.89K
Net Income Q3 2016 · Sep 30, 2015 −$628.89K